Skip to main content
. Author manuscript; available in PMC: 2015 Aug 20.
Published in final edited form as: Cancer Biol Ther. 2009 Nov 27;8(22):2186–2193. doi: 10.4161/cbt.8.22.10446

Figure 2. Stable mutant p53-expressing human DLD1 PG13-EGFP colon cancer cell line increases EGFP expression in response to the p53 pathway restoring small molecule ellipticine.

Figure 2

Cells were seeded 20 hours before ellipticine was added at the concentration indicated at the top of each column to induce the expression of EGFP. The pictures in the middle row are green fluorescence only. The pictures in the bottom row are the bright field and the ones in the top row are combined.